Stifel Financial’s Juno Therapeutics, Inc. JUNO Stock Holding History

Stifel Financial’s Portfolio JUNO Stock Details JUNO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-11,189	Closed	-$514K	–	2826
2017 Q4	$514K	Buy	+11,189	New	+$558K	﹤0.01%	1895
2017 Q3	–	Sell	-11,275	Closed	-$335K	–	2693
2017 Q2	$335K	Sell	11,275 -27,550	-71%	-$680K	﹤0.01%	2076
2017 Q1	$855K	Buy	38,825 +20,525	+112%	+$440K	﹤0.01%	1521
2016 Q4	$356K	Buy	18,300 +7,750	+73%	+$190K	﹤0.01%	1950
2016 Q3	$318K	Buy	+10,550	New	+$328K	﹤0.01%	1956

Other funds holding JUNO

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM

Stifel Financial's JUNO Position: Q1 2018 in Review

Stifel Financial sold out of Juno Therapeutics, Inc. (JUNO) in Q1 2018, closing a stake of 11,189 shares — an estimated $514K sold.

Stifel Financial first reported a position in JUNO in Q3 2016 and held it in 5 quarters. The position peaked at $855K in Q1 2017. 2 funds tracked by Wall St. Rank hold JUNO as of Q1 2018.

Stifel Financial reported no remaining Juno Therapeutics, Inc. position as of Q1 2018 after selling out during the quarter.
Stifel Financial sold 11,189 Juno Therapeutics, Inc. shares in Q1 2018, an estimated $514K.
Stifel Financial first reported a position in Juno Therapeutics, Inc. in Q3 2016 and held it in 5 quarters.
Stifel Financial's Juno Therapeutics, Inc. position peaked at $855K in Q1 2017.
2 funds tracked by Wall St. Rank held Juno Therapeutics, Inc. as of Q1 2018.

Based on Stifel Financial's 13F filing for Q1 2018, filed 11 May 2018.